Showing results (261-270 of 293) with videos related to

Sort By:
Pageof 30
The Lancet. Respiratory Medicine|April 11, 2014
Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational studyTimothy M Walker, Maeve K Lalor, Agnieszka Broda, et al.
Nature Communications|June 6, 2026
Complete genomes reveal a refined map of Mycobacterium tuberculosis genetic diversity across evolutionary scalesAna María García-Marín, Manuela Torres-Puente, Llúcia Martinez-Priego, et al.
Nature Microbiology|August 31, 2016
Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal KenyaAnna C Seale, Angela C Koech, Anna E Sheppard, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Nature Communications|May 12, 2021
Global population structure and genotyping framework for genomic surveillance of the major dysentery pathogen, Shigella sonneiJane Hawkey, Kalani Paranagama, Kate S Baker, et al.
The New England Journal of Medicine|December 28, 2020
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care WorkersSheila F Lumley, Denise O'Donnell, Nicole E Stoesser, et al.
Nature Genetics|February 27, 2007
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosisChiea C Khor, Stephen J Chapman, Fredrik O Vannberg, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 23, 2020
SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020Sheila F Lumley, David W Eyre, Anna L McNaughton, et al.
Pageof 30